New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging;Neue Erkenntnisse der peripartalen Kardiomyopathie durch die Magnetresonanztomografie des Herzens

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 183, Issue 9, 2011, Pages 834-841

  Renz, D M ^a   Rottgen R ^a   Habedank, D ^a   Wagner, M ^a   Bottcher J ^b   Pfeil, A ^c   Dietz, R ^a   Kivelitz, D ^d   Elgeti, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SRH Wald Klinikum Gera   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

heart; MR imaging; peripartum cardiomyopathy; tissue characterization

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CASE REPORT; CLINICAL ARTICLE; DISEASE COURSE; EDEMA; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INFLAMMATION; PERIPARTUM CARDIOMYOPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; CARDIOMYOPATHIES; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEART ATRIA; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIUM; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; REFERENCE VALUES; RETROSPECTIVE STUDIES; STROKE VOLUME; YOUNG ADULT;

EID: 80052314237     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0031-1281600     Document Type: Article

References (40)

1. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006 368 687-693 (Pubitemid 44223695)
2. Pearson G D., Veille J C., Rahimtoola S et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000 283 1183-1188 (Pubitemid 30126607)
3. Sliwa K, Hilfiker-Kleiner D, Petrie M C. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010 12 767-778
4. Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J 2008 29 270-276
5. Ntusi N B., Mayosi B M. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 2009 131 168-179
6. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med 2008 18 173-179
7. Lotz J, Kivelitz D, Fischbach R et al. Empfehlungen für den Einsatz der Computertomographie und Magentresonanztomographie in der Herzdiagnostik. Teil 2 Magnetresonanztomographie. Fortschr Röntgenstr 2009 181 800-814
8. Miller S, Riessen R. MR-tomographische Diagnostik von Kardiomyopathien. Fortschr Röntgenstr 2005 177 1497-1505 (Pubitemid 41686473)
9. Lüders F, Fischbach R, Seifarth H et al. Untersuchung der regionalen und globalen linksventrikulären Funktion mit der Dual-Source- Computertomografie im Vergleich zur Magnetresonanztomografie. Fortschr Röntgenstr 2009 181 962-969
10. Mouquet F, Lions C, Groote P de et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol 2008 18 2765-2769
11. Marmursztejn J, Vignaux O, Goffinet F et al. Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol 2009 137 e63-e64
12. Leurent G, Baruteau A E., Larralde A et al. Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. Int J Cardiol 2009 132 e91-e93
13. Kawano H, Tsuneto A, Koide Y et al. Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Intern Med 2008 47 97-102 (Pubitemid 351377310)
14. Baruteau A E., Leurent G, Martins R P. et al. Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. Int J Cardiol 2010 144 143-145
15. Habedank D, Kühnle Y, Elgeti T et al. Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail 2008 10 1149-1151
16. Friedrich M G., Sechtem U, Schulz-Menger J et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009 53 1475-1487
17. Gutberlet M, Spors B, Thoma T et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008 246 401-409
18. Zagrosek A, Abdel-Aty H, Boyé P et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009 2 131-138
19. Alfakih K, Plein S, Thiele H et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003 17 323-329 (Pubitemid 36259246)
20. Anderson J L., Horne B D., Pennell D J. Atrial dimensions in health and left ventricular disease using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005 7 671-675 (Pubitemid 41176833)
21. Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 2007 118 14-20 (Pubitemid 46517681)
22. Midei M G., DeMent S H., Feldman A M. et al. Peripartum myocarditis and cardiomyopathy. Circulation 1990 81 922-928 (Pubitemid 20090390)
23. Voigt A, Elgeti T, Durmus T et al. Cardiac magnetic resonance imaging in dilated cardiomyopathy in adults-towards identification of myocardial inflammation. Eur Radiol 2011 21 925-935
24. Eitel I, Lücke C, Grothoff M et al. Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eur Radiol 2010 20 422-431
25. Hunold P, Kreitner K F., Barkhausen J. Tot oder lebendig?: Wie und warum myokardiale Vitalitätsdiagnostik mit MRT funktioniert. Fortschr Röntgenstr 2007 179 1016-1024 (Pubitemid 47596613)
26. Muellerleile K, Lund G, Groth M et al. Delayed Enhancement Magnetresonanztomografie bei Patienten mit klinischer Verdachtsdiagnose Stress-Kardiomyopathie (Tako-Tsubo). Fortschr Röntgenstr 2010 182 29-35
27. Winter L, Zellweger M J., Bremerich J. Endomyokardfibrose bei chronisch eosinophiler Leukämie. Fortschr Röntgenstr 2009 181 691-693
28. McCrohon J A., Moon J CC, Prasad S K. et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003 108 54-59 (Pubitemid 36859020)
29. Bohl S, Wassmuth R, Abdel-Aty H et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 2008 24 597-607
30. Fidziaska A, Walczak E, Glinka Z et al. Ultrastructural evidence of myocardial capillary remodeling in peripartum cardiomyopathy. Med Sci Monit 2010 16 CS62-CS66
31. Wu K C., Weiss R G., Thiemann D R. et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008 51 2414-2421 (Pubitemid 351826874)
32. Nassenstein K, Bruder O, Breuckmann F et al. Häufigkeit, Muster und funktionelle Bedeutung des Late Gadolinium Enhancements bei der linksventrikulären Hypertrophie infolge einer Aortenklappenstenose. Fortschr Röntgenstr 2009 181 472-476
33. Krittayaphong R, Boonyasirinant T, Chaithiraphan V et al. Prognostic value of late gadolinium enhancement in hypertensive patients with known or suspected coronary artery disease. Int J Cardiovasc Imaging 2010 26 123-131
34. Abboud J, Murad Y, Chen-Scarabelli C et al. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007 118 295-303 (Pubitemid 46695762)
35. Duran N, Gunes H, Duran I et al. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 2008 101 137-140
36. Elkayam U, Akhter M W., Singh H et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005 11 2050-2055 (Pubitemid 40577899)
37. Fett J D., Christie L G., Murphy J G. Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 2006 145 30-34 (Pubitemid 46780602)
38. Sliwa K, Förster O, Libhaber E et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006 27 441-446 (Pubitemid 43209169)
39. Lin S P., Brown J J. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007 25 884-899
40. Hilfiker-Kleiner D, Kaminski K, Podewski E et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007 128 589-600 (Pubitemid 46206082)